Yuval Cohen

Yuval Cohen

Chief Executive OfficeratCorbus Pharmaceuticals Holdings· In proxies 2022–2025

Pay in FY2023-21% from the year before · Corbus Pharmaceuticals Holdings stock +82.2% the same year

Yuval Cohen was paid $1.1M in FY2023 (Dec), down 21%. Corbus Pharmaceuticals Holdings stock rose 82.2% that year.

Pay$100 in the stock at the end of FY21 → $33
Pay is from the Summary Compensation Table of each Corbus Pharmaceuticals Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Corbus Pharmaceuticals HoldingsPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -78%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?